Top

Published in:

01-03-2012 | Letter to the Editors

A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein

Authors: Jannis Kountouras, Christos Zavos, Emmanuel Gavalas, Georgia Deretzi, Afroditi Tsona, Panagiotis Katsinelos, Savas Grigoriadis, Ioannis Pilpilidis, Dimitrios Tzilves, Elizabeth Vardaka, Konstantinos Mantzoukis, Stergios A. Polyzos

Published in: Cancer Immunology, Immunotherapy | Issue 3/2012

Excerpt

Dear Editors, …

Codolo G et al (2011) HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother. doi:10.1007/s00262-011-1087-2

Li W et al (2009) Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler 15(12):1411–1421PubMedCrossRef

Kountouras J et al (2010) Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult Scler 16(3):376–377PubMedCrossRef

Gavalas E et al (2007) Helicobacter pylori and multiple sclerosis. J Neuroimmunol 188(1–2):187–189PubMedCrossRef

Kountouras J et al (2006) Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66(6):938–940PubMedCrossRef

Kountouras J et al (2008) Guillain-Barré syndrome. Lancet Neurol 7(12):1080–1081PubMedCrossRef

Kountouras J et al (2001) Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 48(39):743–751PubMed

Kountouras J et al (2009) A concept of Helicobacter pylori and stress-secreted mast cells’ potential involvement in brain metastases. J Neuroimmunol 209(1–2):121–122PubMedCrossRef

Kountouras J et al (2011) Helicobacter pylori infection may trigger Guillain–Barré syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci 305(1–2):167–168PubMedCrossRef

10.

Kountouras J (2009) Helicobacter pylori: an intruder involved in conspiring glaucomatous neuropathy. Br J Ophthalmol 93(11):1413–1415PubMedCrossRef

11.

Kountouras J et al (2007) Alzheimer’s disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med Hypotheses 68(2):378–388PubMedCrossRef

12.

Long M et al (2009) Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer. World J Gastroenterol 15(19):2381–2388PubMedCrossRef

13.

Polenghi A et al (2007) The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J Immunol 178(3):1312–1320PubMed

14.

Theoharides TC et al (2008) Impact of stress and mast cells on brain metastases. J Neuroimmunol 205(1–2):1–7PubMedCrossRef

Title: A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein
Authors: Jannis Kountouras
Christos Zavos
Emmanuel Gavalas
Georgia Deretzi
Afroditi Tsona
Panagiotis Katsinelos
Savas Grigoriadis
Ioannis Pilpilidis
Dimitrios Tzilves
Elizabeth Vardaka
Konstantinos Mantzoukis
Stergios A. Polyzos
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 3/2012
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-011-1142-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2012

Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany

Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer

Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice

In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging

SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer